Claritas Rx
Claritas Rx provides a cloud-hosted SaaS platform that aggregates specialty pharmacy, hub, and copay data for biopharma manufacturers, using proprietary AI/ML models to predict therapy discontinuation and improve patient access, refill rates, and care coordination in specialty, rare disease, and cell and gene therapy markets.
- Company typePrivate
- Founded2011
- HeadquartersSouth San Francisco, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Claritas Rx does
Claritas Rx is a US-based, privately held health technology company that provides a cloud-hosted SaaS platform — branded as the Claritas Rx Ascend® Platform — for pharmaceutical manufacturers operating in the specialty, rare disease, cell and gene therapy, and Buy & Bill segments. The platform aggregates and harmonizes patient-level data from specialty pharmacies, hubs, copay programs, specialty distributors, and other sources into a unified longitudinal patient record, then layers analytics, AI-powered risk prediction, omnichannel patient services CRM, consent management, and competitive benchmarking on top. Its core customer base is mid-to-large biopharma manufacturers seeking visibility into patient journeys across complex specialty distribution channels and improved first-fill, refill, and persistence rates.
The underlying technology is a modular, API-first SaaS architecture with HIPAA, GDPR, HITECH, SOC 2, and CCPA compliance built in. It comprises six integrated modules: Foundational Data Aggregation (the data layer), Access Analytics (real-time market access dashboards), Patient Watchtower™ (AI-driven care coordination), Patient Services Omnichannel CRM, Performance Benchmarking, and Consent Clearinghouse™. The company's proprietary AI/ML models claim 80-95% accuracy in predicting therapy discontinuation, prior authorization denials, and prescription abandonment, with a proprietary PHI-matching engine achieving 95%+ patient match accuracy across 5M+ patient-level data records.
Claritas Rx monetizes primarily through enterprise SaaS subscriptions priced per brand, indication, and data volume, with annual contracts and complementary professional services for implementation, data migration, and custom configuration. Distribution is exclusively direct enterprise sales, supported by inside sales and an event-driven marketing motion anchored in major biopharma industry conferences (Asembia, NASP, Hub East/West, Rare Disease Summit). The company reports a 94% customer retention rate and multiple named enterprise customers including Servier, Photocure ASA, and various mid-sized biopharma manufacturers. Founded in 2011 and headquartered in South San Francisco with an additional Philadelphia-area office, Claritas Rx has raised institutional capital from Kiplin Capital and Questa Capital Management.
Claritas Rx firmographics
Firmographics- Name
- Claritas Rx
- Legal name
- Claritas Rx Inc.
- Website
- https://claritasrx.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Claritas Rx provides a cloud-hosted SaaS platform that aggregates specialty pharmacy, hub, and copay data for biopharma manufacturers, using proprietary AI/ML models to predict therapy discontinuation and improve patient access, refill rates, and care coordination in specialty, rare disease, and cell and gene therapy markets.
- Ownership category
- akta.pro rank
Claritas Rx industry classification
Industry- Product category
- Specialty Pharmacy Analytics Software
- NAICS
- Software Publishers (513210), Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
- akta.pro secondary industry
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
Keywords
Where Claritas Rx is headquartered
LocationHeadquarters
- HQ city
- South San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Claritas Rx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Platform Subscription: Claritas Rx operates as a cloud-hosted SaaS platform with subscription-based pricing. The platform is sold as an integrated suite of solutions (Foundational Data Aggregation, Access Analytics, Patient Watchtower, Patient Services Omnichannel CRM, Performance Benchmarking) with modular components that can be bundled based on customer needs. Pricing varies by brand, indication, and data volume.
- Professional Services: Implementation services, training, and custom configuration services to deploy the platform and integrate with client systems. Includes data migration, system integration, workflow configuration, and ongoing customer success support.
- Data Aggregation Services: Foundational Data Aggregation services providing validated, clean, curated data across disparate data sources. This includes data processing, validation, normalization, de-identification, and ongoing data quality monitoring.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription with modular components |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels9 records
Claritas Rx product offering
Product offeringCore offering
Claritas Rx sells the Claritas Rx Ascend® Platform, a cloud-hosted SaaS suite that aggregates and harmonizes fragmented data from specialty pharmacies, hubs, copay programs, distributors, and EMR/claims vendors into a unified longitudinal patient record. The platform layers AI/ML predictive risk profiling, real-time market access dashboards, omnichannel patient services CRM, competitive benchmarking, and centralized consent management on top of that data foundation for biopharma manufacturers commercializing specialty, rare disease, cell & gene, and Buy & Bill therapies.
Product overview
Claritas Rx offers the Claritas Rx Ascend® Platform — a cloud-hosted SaaS platform that unifies real-world specialty pharmaceutical data with advanced analytics, AI, and intelligent case management. The platform operates as a platform-plus-modules architecture with six integrated components: Foundational Data Aggregation (the foundational data layer that aggregates, validates, and harmonizes data from specialty pharmacies, hubs, copay programs, distribution partners, and EMR/claims vendors into a unified longitudinal patient record), Access Analytics (real-time dashboards for market access KPIs across channel, payer, and patient metrics), Patient Watchtower™ (AI-powered care coordination and predictive risk scoring), Patient Services Omnichannel CRM (purpose-built CRM with omnichannel outreach and AI-driven next-best-action recommendations), Performance Benchmarking (competitive intelligence comparing brand KPIs against the industry), and Consent Clearinghouse™ (centralized consent management across all patient touchpoints). The platform achieves +95% patient match accuracy and drives measurable improvements including +20% fill rate increases in complex cases.
Differentiator
Problem solved
Functional benefit
Brands
- Claritas Rx Ascend® Platform: The intelligent platform combining advanced analytics, real-world patient data, AI, and omnichannel CRM tools to help patients start and remain on therapy.
- Patient Watchtower™
- Consent Clearinghouse™
- Foundational Data Aggregation
- Access Analytics
- Performance Benchmarking
Products and services
- Claritas Rx Ascend® Platform The cloud-hosted SaaS platform that unifies real-world specialty pharmaceutical data with advanced analytics, AI, and intelligent case management, and powers all Claritas Rx modules including Foundational Data Aggregation, Access Analytics, Patient Watchtower, Patient Services Omnichannel CRM, Performance Benchmarking, and Consent Clearinghouse for biopharma manufacturers.
- Foundational Data Aggregation The foundational data layer that aggregates, validates, and harmonizes patient data from specialty pharmacies, hubs, copay programs, distribution partners, and EMR/claims vendors into a unified, compliant longitudinal patient record with 95%+ patient match accuracy, built for biopharma manufacturers commercializing specialty and rare disease therapies.
- Access Analytics Real-time market access dashboard solution delivering next-day visibility into brand performance across channel, payer, and patient metrics including enrollments, fill rates, prior authorization, and inventory tracking for biopharma market access and commercial operations teams.
- Patient Watchtower™ AI-powered care coordination platform that combines patient journey analytics with predictive risk profiling and integrated case coordination, built specifically for specialty and rare disease patients so that no patient falls through the cracks.
- Patient Services Omnichannel CRM Purpose-built CRM for patient services teams that unifies case management, omnichannel communication (phone, email, portal, text, fax), and workflow automation across specialty pharmacies, hubs, field teams, and case managers, powered by AI for predictive risk detection and next-best-action recommendations.
- Performance Benchmarking Real-time competitive intelligence solution that enables specialty biopharma brands to compare KPIs — fill rates, abandonment, and time-to-fill — against custom market baskets, therapeutic areas, or the entire industry using direct license data and proprietary aggregated metadata.
- Consent Clearinghouse™ The industry's first dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma, verifying, reconciling, and continuously monitoring patient consent across every connected data source and network partner to give manufacturers real-time visibility and a defensible compliance record.
Quantifiable outcome
- 20% increase in first fill rates in complex cases
- +7 more outcomes
Companies that use Claritas Rx
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles4 records
Claritas Rx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability5 records
Feature7 records
Claritas Rx partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered notable and core.
- Chiesi GroupnotableJoint presentation at the Rare Disease Summit on turning limited rare disease data into powerful insights. Collaboration focuses on rare disease analytics, ethics, and access strategy for patients with limited data visibility.
- HealthVeritycoreStrategic partnership announced October 2025 to unlock more actionable real-world insights for commercial, RWE (Real-World Evidence), and HEOR teams. HealthVerity, as the leader in real-world data technology and privacy-compliant data exchange, integrates with Claritas Rx's patient journey analytics to enhance data capabilities for biopharma customers.
- ServiernotablePartnership spotlighted in Healthcare Digital for leveraging advanced analytics and predictive modeling in the rare disease market. The collaboration focuses on improving patient access and outcomes in rare disease treatments through data-driven solutions.
- Photocure ASAnotableStrategic partnership with Photocure ASA as part of their Hexvix/Cysview bladder cancer detection product strategy. Includes partnership with Claritas and a licensing agreement with Asieris for Cevira with milestone payments tied to regulatory approval in China.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Claritas Rx competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the largest life sciences analytics and RWE company globally, offering patient journey, commercial, and real-world evidence solutions that overlap directly with Claritas Rx's specialty pharma analytics offering, but at much broader scope across clinical and commercial.
- Salesforce (Health Cloud / Life Sciences Cloud): Salesforce Health Cloud and Life Sciences Cloud provide CRM and patient engagement infrastructure for biopharma; a broad incumbent that competes with Claritas Rx's Omnichannel CRM via ecosystem breadth rather than specialty depth.
Direct peers
- Veeva Systems: Veeva's life sciences CRM and patient services suite (Veeva Vault, Veeva CRM) directly serves biopharma commercial and patient services teams, overlapping with Claritas Rx's Omnichannel CRM and Patient Watchtower offerings for specialty pharma manufacturers.
- ZS Associates: ZS is a specialty pharma analytics and consulting firm with deep offerings in patient journey, market access, and AI-driven commercial analytics for biopharma — closely comparable to Claritas Rx's specialty focus and data-driven approach.
- Komodo Health: Komodo Health aggregates real-world patient data and provides patient journey analytics for biopharma, overlapping directly with Claritas Rx's Foundational Data Aggregation and Performance Benchmarking capabilities.
- OptimizeRx: OptimizeRx delivers market access, affordability, and provider engagement solutions for life sciences, comparable to Claritas Rx's Access Analytics and Patient Watchtower offerings around access barriers and therapy initiation.
Emerging players
- Aktana: Aktana provides AI-driven commercial strategy and next-best-action recommendations for life sciences sales and marketing teams, overlapping with Claritas Rx's recommendation engine and predictive patient engagement features.
- ConcertAI: ConcertAI provides real-world evidence and AI solutions for specialty oncology and biopharma, comparable to Claritas Rx's RWE and predictive analytics for specialty/rare disease manufacturers.
- Definitive Healthcare: Definitive Healthcare offers commercial intelligence and analytics for healthcare and life sciences, with overlap to Claritas Rx's Performance Benchmarking and market access analytics products.
- MedHOK (Hearst Health / CoverMyMeds): MedHOK (now part of CoverMyMeds/Hearst Health) provides specialty pharmacy and patient access workflow tools, with adjacent overlap to Claritas Rx's prior authorization, hub, and patient services workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Claritas Rx social profiles
Digital presenceClaritas Rx compliance and trust
Trust signalCompliance5 records
Claritas Rx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Claritas Rx leadership team
Management profileNumber of profiles
Profiles12 records
Claritas Rx funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Claritas Rx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Claritas Rx
What does Claritas Rx do?
Claritas Rx sells the Claritas Rx Ascend® Platform, a cloud-hosted SaaS suite that aggregates and harmonizes fragmented data from specialty pharmacies, hubs, copay programs, distributors, and EMR/claims vendors into a unified longitudinal patient record. The platform layers AI/ML predictive risk profiling, real-time market access dashboards, omnichannel patient services CRM, competitive benchmarking, and centralized consent management on top of that data foundation for biopharma manufacturers commercializing specialty, rare disease, cell & gene, and Buy & Bill therapies.
Is Claritas Rx a public or private company?
Claritas Rx is a private company. It is classified as venture growth investor backed and is currently operating.
When was Claritas Rx founded?
Claritas Rx was founded in 2011. It employs 101 to 250 people.
Where is Claritas Rx based?
Claritas Rx is headquartered in South San Francisco, United States, in the North America region.
How does Claritas Rx make money?
Three revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services and data Aggregation Services.
Who are Claritas Rx's main competitors?
Broad incumbents on record are IQVIA and Salesforce (Health Cloud / Life Sciences Cloud). Direct peers are Veeva Systems, ZS Associates, Komodo Health and OptimizeRx. Emerging players are Aktana, ConcertAI, Definitive Healthcare and MedHOK (Hearst Health / CoverMyMeds).
Does Claritas Rx have an API?
No public API is recorded for Claritas Rx.
What industry is Claritas Rx in?
Claritas Rx's product category is Specialty Pharmacy Analytics Software. Its primary akta.pro industry code is HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms, with a secondary code of HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement. Its NAICS code is 513210 and its SIC code is 7372.